Heartseed Inc.
| Code | Sector | Market |
|---|---|---|
| 219A | Pharmaceuticals | Growth |
| Date of listing approval | 2024/06/26 |
|---|---|
| Expected Date | 2024/07/30 |
| Lead Underwriter | SMBC Nikko SBI SECURITIES Co.,Ltd. |
| Description |
| Listed Shares(total) | 1,801,700 |
|---|---|
| Trading Unit | 100 |
| New Shares | 1,801,700 |
| Existing Shares | 0 |
| Shares Outstanding | PreIPO 20,195,200.00 |
| PostIPO 21,996,900.00 | |
| Paid Up Capital | PreIPO Y50,000,000 |
| PostIPO | |
| Expected Pricing Date | 2024/07/11 |
| Book Building Start | 2024/07/12 |
| Book Building End | 2024/07/19 |
| Fix Date | 2024/07/22 |
| Offering Starts | 2024/07/23 |
| Offering Ends | 2024/07/26 |
| Expect Pricing | - |
| Notional PER (based on previous period) |
- |
| Offering Price | |
| Offering Price PER (based on previous period) |
- |
| Offering Price PBR (based on previous period) |
|
| Use of Funds Raised |
Financial Data
Units:Y1,000
| Fiscal Year End:2021/10 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | - | 1,635,000 |
| Current Profit | - | -255,341 |
| Net Profit | - | -257,890 |
| Net Assets | - | 6,139,588 |
| Fiscal Year End:2022/10 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | - | 499,060 |
| Current Profit | - | -1,410,304 |
| Net Profit | - | -1,412,728 |
| Net Assets | - | 4,727,553 |
| Fiscal Year End:2023/10 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | - | 344,725 |
| Current Profit | - | -1,456,584 |
| Net Profit | - | -1,473,500 |
| Net Assets | - | 5,269,559 |
| Recent Quarter 2024/04 |
||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | - | 153,210 |
| Current Profit | - | -719,483 |
| Net Profit | - | -720,225 |
| Net Assets | - | 4,549,120 |
Per Share Units:Y1
| Fiscal Year End:2021/10 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | 0.00 | |
| Net Earning | - | - |
| Equity | -23.63 | -89.78 |
| Fiscal Year End:2022/10 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | 0.00 | |
| Net Earning | - | - |
| Equity | -128.99 | -218.77 |
| Fiscal Year End:2023/10 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | 0.00 | |
| Net Earning | - | - |
| Equity | -106.81 | -353.31 |
| Fiscal Year End:Interim Results 2024/04 |
||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | ||
| Net Earning | - | -58.69 |
| Equity | - | - |
Comment
| ąŁOver allotment(270,200) |
Consolidated Subsidiaries
| Name | Address |
|---|
Underwriters
| Allocation | Underwriter | Tel |
|---|---|---|
| 0% | Nomura | 03-3211-1811 |
| 0% | SMBC Nikko | 03-5644-3111 |
| 0% | SBI SECURITIES Co.,Ltd. | 03-5562-7210 |
| 0% | Nomura | 03-3211-1811 |
| 0% | Rakuten Securities | 03-6406-2681 |
| 0% | Matsui | 03-5216-0606 |
| 0% | Monex | 03-4323-3800 |
| 0% | Kyokuto | 03-3667-9171 |
Data
| Date of incorporation | 2015/11/30 |
|---|---|
| Company address | Tokyo 105-0023 |
| Telephone | 03-6665-8068 |
| President | |
| Homepage | https://heartseed.jp/ |
| Auditor | EY Shin Nihon |
| Major Shareholders | |
|---|---|
| Shareholder Name | Ratio |
| 86.62% | |
| 15.09% | |
| 10.55% | |
| 8.92% | |
| 7.26% | |
| 5.28% | |
| 5.28% | |
| 3.77% | |
| 3.34% | |
| 2.29% | |
| 2.27% | |
| Number of Employees | 39 as of 2024/05/31 |
|---|---|
| Birth Date of Representative | 1957/05/23 |